No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr6:44523000-44531000 |
Weak transcription |
Ovary |
ovary
|
2 |
chr6:44524000-44531000 |
Weak transcription |
Gastric |
stomach
|
3 |
chr6:44526600-44531000 |
Weak transcription |
Right Atrium |
heart
|
4 |
chr6:44527600-44535400 |
Weak transcription |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
5 |
chr6:44528000-44529600 |
Weak transcription |
HUES6 Cell Line |
embryonic stem cell
|
6 |
chr6:44528000-44532600 |
Weak transcription |
HUES48 Cell Line |
embryonic stem cell
|
7 |
chr6:44528400-44529400 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
8 |
chr6:44528600-44529400 |
Enhancers |
HUES64 Cell Line |
embryonic stem cell
|
9 |
chr6:44528600-44529400 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
10 |
chr6:44528600-44529400 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
11 |
chr6:44528600-44529800 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
12 |
chr6:44528600-44529800 |
Enhancers |
Fetal Lung |
lung
|
13 |
chr6:44528600-44530200 |
Enhancers |
Fetal Thymus |
thymus
|
14 |
chr6:44528800-44529400 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
15 |
chr6:44528800-44529400 |
Active TSS |
Primary T cells from cord blood |
blood
|
16 |
chr6:44528800-44529400 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
17 |
chr6:44528800-44529400 |
Bivalent Enhancer |
Primary T helper cells PMA-I stimulated |
--
|
18 |
chr6:44528800-44529400 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
19 |
chr6:44528800-44529400 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
20 |
chr6:44528800-44529600 |
Weak transcription |
ES-WA7 Cell Line |
embryonic stem cell
|
21 |
chr6:44528800-44529800 |
Bivalent Enhancer |
Adipose Nuclei |
Adipose
|
22 |
chr6:44528800-44530000 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
23 |
chr6:44529000-44529400 |
Bivalent/Poised TSS |
Brain Hippocampus Middle |
brain
|
24 |
chr6:44529000-44529400 |
Flanking Bivalent TSS/Enh |
Fetal Adrenal Gland |
Adrenal Gland
|
25 |
chr6:44529000-44529400 |
Flanking Bivalent TSS/Enh |
Fetal Muscle Leg |
muscle
|
26 |
chr6:44529000-44529400 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
27 |
chr6:44529000-44529400 |
Flanking Bivalent TSS/Enh |
Monocytes-CD14+_RO01746 |
blood
|
28 |
chr6:44529000-44529400 |
Bivalent/Poised TSS |
Osteobl |
bone
|
29 |
chr6:44529000-44529600 |
Enhancers |
Primary B cells from cord blood |
blood
|
30 |
chr6:44529000-44529800 |
Enhancers |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
31 |
chr6:44529000-44529800 |
Enhancers |
Lung |
lung
|
32 |
chr6:44529000-44530000 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
33 |
chr6:44529000-44530000 |
Enhancers |
iPS-18 Cell Line |
embryonic stem cell
|
34 |
chr6:44529000-44530200 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
35 |
chr6:44529000-44531000 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
36 |
chr6:44529200-44529400 |
Flanking Bivalent TSS/Enh |
Fetal Stomach |
stomach
|
37 |
chr6:44529200-44529400 |
Enhancers |
Psoas Muscle |
Psoas
|
38 |
chr6:44529200-44529400 |
Flanking Bivalent TSS/Enh |
Dnd41 |
blood
|
39 |
chr6:44529200-44529600 |
Active TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
40 |
chr6:44529200-44529800 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
41 |
chr6:44529200-44529800 |
Bivalent Enhancer |
Primary mononuclear cells fromperipheralblood |
Blood
|
42 |
chr6:44529200-44530200 |
Enhancers |
Thymus |
Thymus
|
43 |
chr6:44529200-44530600 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
44 |
chr6:44529200-44531200 |
Weak transcription |
Pancreas |
Pancrea
|
45 |
chr6:44529200-44531400 |
Weak transcription |
Brain Substantia Nigra |
brain
|